Krefting, F., Hölsken, S., Sondermann, W., & Schedlowski, M. (2025). Hypothalamic pituitary adrenal axis hormone changes during IL-17A inhibition with secukinumab in patients with psoriasis. Clinical immunology (Orlando, Fla.), 282, 110611. https://doi.org/10.1016/j.clim.2025.110611
Chicago ZitierstilKrefting, F., S. Hölsken, W. Sondermann, und M. Schedlowski. "Hypothalamic Pituitary Adrenal Axis Hormone Changes During IL-17A Inhibition with Secukinumab in Patients with Psoriasis." Clinical Immunology (Orlando, Fla.) 282 (2025): 110611. https://dx.doi.org/10.1016/j.clim.2025.110611.
MLA ZitierstilKrefting, F., et al. "Hypothalamic Pituitary Adrenal Axis Hormone Changes During IL-17A Inhibition with Secukinumab in Patients with Psoriasis." Clinical Immunology (Orlando, Fla.), vol. 282, 2025, p. 110611.